Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brase

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Bioinformatics (Oxford, England)|July 2, 2010
Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratification of cancer patientsMarc Johannes, Jan C Brase, Holger Fröhlich, et al.
International Journal of Cancer|May 18, 2010
Circulating miRNAs are correlated with tumor progression in prostate cancerJan C Brase, Marc Johannes, Thorsten Schlomm, et al.
BMC Bioinformatics|December 23, 2011
Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancerStephan Gade, Christine Porzelius, Maria Fälth, et al.
Proteome Science|June 24, 2010
Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplificationJan C Brase, Heiko Mannsperger, Holger Fröhlich, et al.
Gynecologic Oncology|May 24, 2011
Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavageAnne-Kathleen Rupp, Christian Rupp, Sascha Keller, et al.
Journal of Clinical Pathology|March 27, 2012
Comparison of the RNA-based EndoPredict multigene test between core biopsies and corresponding surgical breast cancer sectionsBerit Maria Müller, Jan C Brase, Franziska Haufe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and predictionJan C Brase, Marcus Schmidt, Thomas Fischbach, et al.
Plos One|April 5, 2013
ERG induces epigenetic activation of Tudor domain-containing protein 1 (TDRD1) in ERG rearrangement-positive prostate cancerLukasz A Kacprzyk, Mark Laible, Tatjana Andrasiuk, et al.
International Journal of Molecular Sciences|March 6, 2013
A Cancer-Indicative microRNA Pattern in Normal Prostate TissueOlaf J C Hellwinkel, Christina Sellier, Yu-Mi Jessica Sylvester, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 5, 2012
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancerRuprecht Kuner, Maria Fälth, Nicole Chui Pressinotti, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Bioinformatics (Oxford, England)|July 2, 2010
Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratification of cancer patientsMarc Johannes, Jan C Brase, Holger Fröhlich, et al.
International Journal of Cancer|May 18, 2010
Circulating miRNAs are correlated with tumor progression in prostate cancerJan C Brase, Marc Johannes, Thorsten Schlomm, et al.
BMC Bioinformatics|December 23, 2011
Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancerStephan Gade, Christine Porzelius, Maria Fälth, et al.
Proteome Science|June 24, 2010
Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplificationJan C Brase, Heiko Mannsperger, Holger Fröhlich, et al.
Gynecologic Oncology|May 24, 2011
Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavageAnne-Kathleen Rupp, Christian Rupp, Sascha Keller, et al.
Journal of Clinical Pathology|March 27, 2012
Comparison of the RNA-based EndoPredict multigene test between core biopsies and corresponding surgical breast cancer sectionsBerit Maria Müller, Jan C Brase, Franziska Haufe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and predictionJan C Brase, Marcus Schmidt, Thomas Fischbach, et al.
Plos One|April 5, 2013
ERG induces epigenetic activation of Tudor domain-containing protein 1 (TDRD1) in ERG rearrangement-positive prostate cancerLukasz A Kacprzyk, Mark Laible, Tatjana Andrasiuk, et al.
International Journal of Molecular Sciences|March 6, 2013
A Cancer-Indicative microRNA Pattern in Normal Prostate TissueOlaf J C Hellwinkel, Christina Sellier, Yu-Mi Jessica Sylvester, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 5, 2012
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancerRuprecht Kuner, Maria Fälth, Nicole Chui Pressinotti, et al.
Pageof 6